Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Retatrutide

TRIUMPH-1

Eli Lilly · Phase 3 · Completed · Enrollment 2335

NCT05929066

ArmPopulationDoseWeeksEstimandWeight change
retatrutide 4 mgObesity, no T2D4 mg80ITT-17.6% at week 80
retatrutide 9 mgObesity, no T2D9 mg80ITT-23.7% at week 80
retatrutide 12 mgObesity, no T2D12 mg80ITT-25% at week 80
PlaceboObesity, no T2Dn/r80ITT-3.9% at week 80